-
281
Waning neutralizing antibodies through 180 days after homologous and heterologous boosters of inactivated COVID-19 vaccine
Published 2025-01-01Subjects: Get full text
Article -
282
SARS-CoV-2 transmission dynamics in Mozambique and Zimbabwe during the first 3 years of the pandemic
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
283
Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes
Published 2024-12-01Subjects: “…SARS-CoV-2 vaccine…”
Get full text
Article -
284
Kidney damage associated with COVID-19: from the acute to the chronic phase
Published 2024-12-01Subjects: Get full text
Article -
285
Comparison of Two Field Deployable PCR Platforms for SARS-CoV-2 and Influenza A and B Viruses’ Detection
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
286
Neurological post-COVID syndrome is associated with substantial impairment of verbal short-term and working memory
Published 2025-01-01Subjects: Get full text
Article -
287
SPR Biosensor Based on Bilayer MoS<sub>2</sub> for SARS-CoV-2 Sensing
Published 2025-01-01Subjects: Get full text
Article -
288
Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
289
Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022–2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
290
Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
Published 2025-01-01Subjects: “…SARS-CoV-2 variants…”
Get full text
Article -
291
New-onset gastrointestinal disorders in COVID-19 patients 3.5 years post-infection in the inner-city population in the Bronx
Published 2024-12-01Subjects: Get full text
Article -
292
Isothermal Evaporation Rate of Deposited Liquid Aerosols and the SARS-CoV-2 Coronavirus Survival
Published 2020-11-01Subjects: “…SARS-CoV-2 coronavirus…”
Get full text
Article -
293
A randomized, placebo-controlled trial of the BTK inhibitor zanubrutinib in hospitalized patients with COVID-19 respiratory distress: immune biomarker and clinical findings
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
294
Evaluation of a flow cytometry-based surrogate assay (FlowSA) for the detection of SARS-CoV-2 in clinical samples
Published 2025-02-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
295
-
296
Caracterización clínica, humoral y epidemiológica de pacientes graves y críticos con la COVID-19
Published 2021-05-01Subjects: Get full text
Article -
297
The impact of COVID-19 pandemic on sleep duration and mental health among middle school students: a 3-year cross-sectional survey
Published 2025-01-01Subjects: “…SARS-CoV-2…”
Get full text
Article -
298
SARS-CoV-2 SPIKE Antibody Levels can Indicate Immuno-Resilience to Re-infection: a Real-World Study
Published 2024-12-01Subjects: Get full text
Article -
299
-
300
Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults
Published 2025-01-01Subjects: Get full text
Article